Coverage policy updates

Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.

Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.

Recorded changes

83,427 on record

Recorded policy changes, newest first
Recorded	Payer	Policy	Change
Aug 2, 2026	Blue Cross of Idaho	Balloon Dilation of the Eustachian TubePayerPolicy · BCIDAHO-07-01-158	New policy
Aug 2, 2026	Blue Cross of Idaho	Chelation Therapy for Off-Label UsesPayerPolicy · BCIDAHO-08-01-002	New policy
Aug 2, 2026	Blue Cross of Idaho	Autografts and Allografts in the Treatment of Focal Articular Cartilage LesionsPayerPolicy · BCIDAHO-07-01-078	New policy
Aug 2, 2026	Blue Cross of Idaho	Balloon Spacers for Treatment of Irreparable Rotator Cuffs of the ShoulderPayerPolicy · BCIDAHO-07-01-180	New policy
Aug 2, 2026	Blue Cross of Idaho	Immersive Virtual Reality Therapy for Chronic Lower Back Pain. Medical Policy MP 3.03.06 Immersive Virtual Reality Therapy for Chronic Lower Back Pain DISCLAIMER/INSTRUCTIONS FOR USE ThisPayerPolicy · BCIDAHO-03-03-006-1AA26CC0C6	New policy
Aug 2, 2026	Blue Cross of Idaho	Immersive Virtual Reality Therapy for Chronic Lower Back Pain. Medical Policy MP 3.03.07 Audio-Visual Neuromodulation for Neuropathic Pain DISCLAIMER/INSTRUCTIONS FOR USE This medical policyPayerPolicy · BCIDAHO-03-03-007-DD04A7A0C5	New policy
Aug 2, 2026	Blue Cross of Idaho	Yartemlea (narsoplimab-wuug). Medical Policy MP 5.01.677 Yartemlea (narsoplimab-wuug) DISCLAIMER/INSTRUCTIONS FOR USE This medical policy provides general guidance for applying Blue Cross ofPayerPolicy · BCIDAHO-05-01-677-908C17A2C2	New policy
Aug 2, 2026	Blue Cross of Idaho	Exdensur (depemokimab-ulaa). Medical Policy MP 5.01.678 Exdensur (depemokimab-ulaa) DISCLAIMER/INSTRUCTIONS FOR USE This medical policy provides general guidance for applying Blue Cross ofPayerPolicy · BCIDAHO-05-01-678-5E1913065A	New policy
Aug 2, 2026	Blue Cross of Idaho	Implantable Shock Absorbers for Treatment of Knee Osteoarthritis. Medical Policy MP 7.01.90 Implantable Shock Absorbers for Treatment of Knee Osteoarthritis DISCLAIMER/INSTRUCTIONS FOR USE ThisPayerPolicy · BCIDAHO-07-01-090-D27FCD966A	New policy
Aug 2, 2026	Blue Cross of Idaho	Treatment for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)PayerPolicy · BCIDAHO-05-01-667	New policy
Aug 2, 2026	Blue Cross of Idaho	Entyvio (vedolizumab) for Inflammatory Bowel Disease. Medical Policy MP 5.01.662 Entyvio (vedolizumab) for Inflammatory Bowel Disease DISCLAIMER/INSTRUCTIONS FOR USE This medical policyPayerPolicy · BCIDAHO-05-01-662-39A3C47F51	New policy
Aug 2, 2026	Blue Cross of Idaho	Entyvio (vedolizumab) for Inflammatory Bowel Disease. Medical Policy MP 5.01.662 Entyvio (vedolizumab) for Inflammatory Bowel Disease DISCLAIMER/INSTRUCTIONS FOR USE This medical policyPayerPolicy · BCIDAHO-05-01-662-CAC5D15BB8	New policy
Aug 2, 2026	Blue Cross of Idaho	Evaluation of Biomarkers for Alzheimer Disease. Medical Policy MP 2.04.514 Evaluation of Biomarkers for Alzheimer Disease DISCLAIMER/INSTRUCTIONS FOR USE This medical policy provides generalPayerPolicy · BCIDAHO-02-04-514-E73E46107C	New policy
Aug 2, 2026	Blue Cross of Idaho	Evaluation of Biomarkers for Alzheimer Disease. Medical Policy MP 2.04.514 Evaluation of Cerebrospinal Fluid, Urine and Plasma for Alzheimer Disease DISCLAIMER/INSTRUCTIONS FOR USE This medicalPayerPolicy · BCIDAHO-02-04-514-981F75DF14	New policy
Aug 2, 2026	Blue Cross of Idaho	Hematopoietic Cell Transplantation for Autoimmune Diseases. Medical Policy MP 8.01.25 Hematopoietic Cell Transplantation for Autoimmune Diseases DISCLAIMER/INSTRUCTIONS FOR USE This medicalPayerPolicy · BCIDAHO-08-01-025-E20B8F98E2	New policy
Aug 2, 2026	Blue Cross of Idaho	Brineura (cerliponase alfa)PayerPolicy · BCIDAHO-05-01-661	New policy
Aug 2, 2026	Blue Cross of Idaho	Evenity (romosozumab-aqqg)PayerPolicy · BCIDAHO-05-01-675	New policy
Aug 2, 2026	Blue Cross of Idaho	Papzimeos (zopapogene imadenovec-drba)PayerPolicy · BCIDAHO-05-01-676	New policy
Aug 2, 2026	Blue Cross of Idaho	Low Level Laser TherapyPayerPolicy · BCIDAHO-02-01-056	New policy
Aug 2, 2026	Blue Cross of Idaho	Leadless Cardiac PacemakersPayerPolicy · BCIDAHO-02-02-032	New policy
Aug 2, 2026	Blue Cross of Idaho	Charged-Particle (Proton or Helium Ion) Radiotherapy for Neoplastic ConditionsPayerPolicy · BCIDAHO-08-01-010	New policy
Aug 2, 2026	Blue Cross of Idaho	Leqvio (inclisiran). Medical Policy MP 5.01.663 Leqvio (inclisiran) DISCLAIMER/INSTRUCTIONS FOR USE This medical policy provides general guidance for applying Blue Cross of Idaho benefit plansPayerPolicy · BCIDAHO-05-01-663-FUTURE	New policy
Aug 2, 2026	Blue Cross of Idaho	Leqvio (inclisiran)PayerPolicy · BCIDAHO-05-01-663	New policy
Aug 2, 2026	Blue Cross of Idaho	Intravenous TocilizumabPayerPolicy · BCIDAHO-05-01-666	New policy
Aug 2, 2026	Blue Cross of Idaho	Bariatric Surgery. Type of service Surgery Place of service Inpatient POLICY HISTORY Date Action Description 02/25/21 Replace policy Blue Cross of Idaho adopted changes as noted, effectivePayerPolicy · BCIDAHO-07-01-547-4E2576F96A	New policy
Aug 2, 2026	Blue Cross of Idaho	Transcatheter Arterial Chemoembolization to Treat Primary or Metastatic Liver MalignanciesPayerPolicy · BCIDAHO-08-01-011-1714FD931B	New policy
Aug 2, 2026	Blue Cross of Idaho	Fractional Carbon Dioxide (CO2) Laser Ablation Treatment of Hypertrophic Scars or Keloids for Functional ImprovementPayerPolicy · BCIDAHO-02-01-107	New policy
Aug 2, 2026	Blue Cross of Idaho	Percutaneous Electrical Nerve Field Stimulation for Irritable Bowel SyndromePayerPolicy · BCIDAHO-02-01-106-AC47C17EAB	New policy
Aug 2, 2026	Blue Cross of Idaho	Medicare Part B Medical Drugs Step Therapy. Medical Policy MP 5.01.610 Medicare Advantage Part B Medical Drugs Step Therapy DISCLAIMER/INSTRUCTIONS FOR USE This medical policy provides generalPayerPolicy · BCIDAHO-05-01-610-A8833CA763	New policy
Aug 2, 2026	Blue Cross of Idaho	Medicare Part B Medical Drugs Step Therapy. Medical Policy MP 5.01.610 Medicare Advantage Part B Medical Drugs Step Therapy DISCLAIMER/INSTRUCTIONS FOR USE This medical policy provides generalPayerPolicy · BCIDAHO-05-01-610-C96146C506	New policy
Aug 2, 2026	Blue Cross of Idaho	Cryoablation of Tumors Located in the Kidney, Lung, Breast, Pancreas, or Bone. Type of Service Surgery Place of Service Outpatient/Inpatient POLICY HISTORY Date Action Description 07/27/20PayerPolicy · BCIDAHO-07-01-092-AAF3171DFD	New policy
Aug 2, 2026	Blue Cross of Idaho	Dopamine Transporter Imaging With Single-Photon Emission Computed Tomography. G31.83 Neurocognitive disorder with Lewy bodies ICD10-PCS ICD-10-PCS codes are only used for inpatient services.PayerPolicy · BCIDAHO-06-01-054-035150099B	New policy
Aug 2, 2026	Blue Cross of Idaho	Outpatient Speech Therapy. MP 8.03.503 Outpatient Speech Therapy (ST) 92615 Interpretation and report only 92616 Flexible endoscopic evaluation of swallowing and laryngeal sensory testing byPayerPolicy · BCIDAHO-08-03-503-C5E232531B	New policy
Aug 2, 2026	Blue Cross of Idaho	Testing and Treatment for Recurrent Pregnancy Loss. 86828, 86829 Antibody to human leukocyte antigens (HLA), solid phase assays (e.g., microspheres or beads, ELISA, flow cytometry); qualitativePayerPolicy · BCIDAHO-04-02-510-C6A2C0AF75	New policy
Aug 2, 2026	Blue Cross of Idaho	Selected Positron Emission Tomography Technologies for Evaluation of Alzheimer DiseasePayerPolicy · BCIDAHO-06-01-555-846C2CE0F5	New policy
Aug 2, 2026	Blue Cross of Idaho	Synthetic Cartilage Implants for Joint PainPayerPolicy · BCIDAHO-07-01-160-D9A961CF75	New policy
Aug 2, 2026	Blue Cross of Idaho	Medical Drugs Not Eligible for Reimbursement. Medical Policy MP 5.01.502 Medical Drugs Not Eligible for Reimbursement DISCLAIMER/INSTRUCTIONS FOR USE This medical policy provides generalPayerPolicy · BCIDAHO-05-01-502-0189625F18	New policy
Aug 2, 2026	Blue Cross of Idaho	Medical Drugs Not Eligible for Reimbursement. Medical Policy MP 5.01.502 Medical Drugs Not Eligible for Reimbursement DISCLAIMER/INSTRUCTIONS FOR USE This medical policy provides generalPayerPolicy · BCIDAHO-05-01-502-5AA3DCC42F	New policy
Aug 2, 2026	Blue Cross of Idaho	Pharmacologic CompoundsPayerPolicy · BCIDAHO-05-01-650	New policy
Aug 2, 2026	Blue Cross of Idaho	Tepezza (teprotumumab-trbw)PayerPolicy · BCIDAHO-05-01-660	New policy
Aug 2, 2026	Blue Cross of Idaho	Lumbar Spinal FusionPayerPolicy · BCIDAHO-07-01-141	New policy
Aug 2, 2026	Blue Cross of Idaho	Noninvasive Techniques for the Evaluation and Monitoring of Patients With Chronic Liver Disease. references addedPayerPolicy · BCIDAHO-02-04-041-2B30D19C11	New policy
Aug 2, 2026	Blue Cross of Idaho	Monoclonal Antibodies for Treatment of Alzheimer DiseasePayerPolicy · BCIDAHO-05-01-538	New policy
Aug 2, 2026	Blue Cross of Idaho	Laparoscopic, Percutaneous, and Transcervical Techniques for Uterine Fibroid MyolysisPayerPolicy · BCIDAHO-04-01-019	New policy
Aug 2, 2026	Blue Cross of Idaho	Intravenous Monoclonal Antibody Therapy for Migraine HeadachePayerPolicy · BCIDAHO-05-01-529	New policy
Aug 2, 2026	Blue Cross of Idaho	Pneumatic Compression Pumps for Treatment of Lymphedema and Venous UlcersPayerPolicy · BCIDAHO-01-01-518	New policy
Aug 2, 2026	Blue Cross of Idaho	Neuropsychological TestingPayerPolicy · BCIDAHO-03-01-508	New policy
Aug 2, 2026	Blue Cross of Idaho	Catheter Ablation as Treatment for Atrial FibrillationPayerPolicy · BCIDAHO-02-02-019	New policy
Aug 2, 2026	Blue Cross of Idaho	Intraoperative Neurophysiologic MonitoringPayerPolicy · BCIDAHO-07-01-058	New policy
Aug 2, 2026	Blue Cross of Idaho	Gene Therapies for ThalassemiaPayerPolicy · BCIDAHO-05-01-042	New policy